| EPD138 | Retention strategies in the first Pre-Exposure Prophylaxis (PrEP) observational cohort among those on community supervision in the South: lessons learned during the SARS-COV-2 pandemic | E-poster | Prisoners and other incarcerated people |
| EPC448 | Retention on treatment and mortality of methadone maintenance therapy patients before and after take-home dosing policy change during COVID-19 pandemic in Ukraine | E-poster | Effects of the COVID-19 on HIV epidemiology and prevention |
| EPC321 | Retention of clients on daily oral HIV pre-exposure prophylaxis in Vietnam | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPB086 | Retention in care in pregnant HIV positive Kaposi Sarcoma (KS) patients seen at a tertiary hospital in Harare, Zimbabwe: a case control study | E-poster | Malignancies (AIDS and non-AIDS) |
| EPE421 | Responding to the COVID-19 pandemic: HIV continuing professional development virtual seminars for healthcare workers in Ukraine | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| OAE0202 | Responding to the challenges of a dual pandemic: how outreach mobile health clinics maintained HIV testing and linkage services in the face of COVID-19 | Oral abstract session with live Q&A | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPD048 | Responding to high prevalence of sexualised drug use among MSM in East and South East Asia requires consistency in construct definition and measurement: results from systematic review and meta-analysis | E-poster | Strengthening social and behavioural data collection and analysis |
| EPE208 | Resource estimation tool used to develop, monitor, and coordinate sustainable, integrated national and provincial sustainable HIV program financing in Vietnam | E-poster | Transitional financing |
| EPB235 | Resistance mutations in the HIV integrase coding region among INSTI-naïve pregnant women in Argentina: a baseline survey | E-poster | Resistance to ART |
| EPB239 | Resistance analysis of long-acting lenacapavir in treatment-naïve people with HIV at 54 weeks | E-poster | Resistance to ART |